Dermatol Clin. 2005 Apr;23(2):335-42.

Adverse drug interactions and reactions in dermatology: current issues of clinical relevance.

Source

Division of Dermatology, Department of Medicine, University of Toronto, Canada.

Abstract

This article highlights several adverse drug interactions and reactions relevant to current dermatologic practice. Absorption interactions between drugs and compounds containing polyvalent cations, potential interactions between herbal and conventional medicines, the meaning of sulfa allergy, and adverse cutaneous reactions caused by epidermal growth factor receptor inhibitors are discussed.

PMID:: 15837159; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms

Publication Types

MeSH Terms

LinkOut - more resources

Full Text Sources

Medical

Drug Reactions - MedlinePlus Health Information

Supplemental Content

Related citations

Serious cutaneous adverse reactions to traditional Chinese medicines. [Singapore Med J. 2005]
Serious cutaneous adverse reactions to traditional Chinese medicines.
Lim YL, Thirumoorthy T. Singapore Med J. 2005 Dec; 46(12):714-7.
Review Adverse effects associated with herbal medicine. [Aust Fam Physician. 2001]
Review Adverse effects associated with herbal medicine.
Pinn G. Aust Fam Physician. 2001 Nov; 30(11):1070-5.
Review Dermatologic manifestations of complementary therapy. [Skinmed. 2003]
Review Dermatologic manifestations of complementary therapy.
Witkowski JA, Parish LC. Skinmed. 2003 May-Jun; 2(3):175-80.
Review [Cutaneous side effects due to psychiatric drugs]. [Vertex. 2008]
Review [Cutaneous side effects due to psychiatric drugs].
Rebok F, Pérez Roldán ML, Daray FM. Vertex. 2008 Nov-Dec; 19(82):348-56.
Adverse interactions between herbal and dietary substances and prescription medications: a clinical survey. [Altern Ther Health Med. 2007]
Adverse interactions between herbal and dietary substances and prescription medications: a clinical survey.
Bush TM, Rayburn KS, Holloway SW, Sanchez-Yamamoto DS, Allen BL, Lam T, So BK, Tran de H, Greyber ER, Kantor S, et al. Altern Ther Health Med. 2007 Mar-Apr; 13(2):30-5.

See reviews... See all...

Cited by 1 PubMed Central article

Use of probabilistic modeling within a physiologically based pharmacokinetic model to predict sulfamethazine residue withdrawal times in edible tissues in swine. [Antimicrob Agents Chemother. 2006]
Use of probabilistic modeling within a physiologically based pharmacokinetic model to predict sulfamethazine residue withdrawal times in edible tissues in swine.
Buur J, Baynes R, Smith G, Riviere J. Antimicrob Agents Chemother. 2006 Jul; 50(7):2344-51.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Adverse drug interactions and reactions in dermatology: current issues of clinic...
Adverse drug interactions and reactions in dermatology: current issues of clinical relevance.
Dermatol Clin. 2005 Apr ;23(2):335-42.

PubMed
Metabolic activity determines efficacy of macroautophagic clearance of pathologi...
Metabolic activity determines efficacy of macroautophagic clearance of pathological oligomeric alpha-synuclein.
Am J Pathol. 2009 Aug ;175(2):736-47. Epub 2009 Jul 23 .

PubMed
ATF-2 is preferentially activated by stress-activated protein kinases to mediate...
ATF-2 is preferentially activated by stress-activated protein kinases to mediate c-jun induction in response to genotoxic agents.
EMBO J. 1995 Apr 18 ;14(8):1798-811.

PubMed
Activating transcription factor-2 DNA-binding activity is stimulated by phosphor...
Activating transcription factor-2 DNA-binding activity is stimulated by phosphorylation catalyzed by p42 and p54 microtubule-associated protein kinases.
Mol Endocrinol. 1992 Dec ;6(12):2079-89.

PubMed
ATF-2 contains a phosphorylation-dependent transcriptional activation domain.
ATF-2 contains a phosphorylation-dependent transcriptional activation domain.
EMBO J. 1995 Apr 18 ;14(8):1785-97.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to: